ɬÀï·¬

A Year of (Bio)chemical Elements

For May, it’s in your bones: calcium and phosphorus

Quira Zeidan
May 1, 2019

The International Year of the Periodic Table marks the 150th anniversary of Dimitri Mendeleev’s periodic system. The ɬÀï·¬ is joining the celebration with a series of articles on biochemical elements. Since January, we have presented hydrogen; iron; sodium, potassium and chlorine; and copper.

CALCIUM & PHOSPHORUS An electrical impulse traveling from a motor neuron results in the release of calcium from the muscle’s intracellular stores. Ca+2 binds to the inhibitory troponin-tropomyosin complex, allowing myosin and actin filaments to slide past one another causing muscle contraction. Adenosine triphosphate is hydrolyzed in the process. Relaxation follows when cytoplasmic calcium is removed.

May is arthritis awareness month, so we selected calcium and phosphorous, the two components of the mineral salt hydroxyapatite that makes up about 65 percent of the human .

With chemical symbol Ca and atomic number 20, calcium is classified in the periodic table as an alkaline earth metal. In chemical reactions, calcium easily loses the two valence electrons in its outermost orbital to form ionic compounds that contain dipositive Ca+2.

At 3 percent of the Earth crust’s mass, calcium is the fifth most abundant element and the third most common metal after iron and aluminum. Most of the Earth’s calcium is found as a carbonate mineral in limestone — sedimentary rock that contains fossilized sea life. Calcium carbonate makes corals, sea shells and pearls when Ca+2 released by weathering reacts with seawater bicarbonate.

Calcium is essential in biology. Both prokaryotes and eukaryotes maintain low intracellular free Ca+2 via ion channels, transporters and calcium-sequestering proteins. In response to environmental changes, intracellular Ca+2 rapidly rises, transmitting the outside information to the interior of the cell. In bacteria, this regulates chemotaxis — or movement toward a chemical stimulus — and flagellar rotation.

In mammals, cells respond to hormones by activating the phosphoinositide 3-kinase signaling pathway that leads to high intracellular Ca+2 and expression of calcium-dependent genes. Excited neurons release the neurotransmitter acetylcholine, which binds to its receptor on the receiving cell, opening ion channels and allowing the influx of extracellular Ca+2. At synapses, the inflow of calcium propagates the electrical signal to the receiving neuron, and at neuromuscular junctions, it triggers muscle contraction in the receiving fiber.

Phosphorus — with chemical symbol P and atomic number 15 — is a reactive nonmetal that combines with other elements mainly by sharing electrons via covalent bonds. Free phosphorus is rare; the element normally is found in compounds in oxidation states of +3, +5 and -3.

Phosphorus is the 11th most common element on Earth. About one gram of phosphate is found for every kilogram of the Earth’s crust, mostly in the form of oxidized inorganic rocks formed over millions of years.

. Some bacteria derive energy for growth by oxidizing H2PO3– or phosphite to inorganic phosphate. Phosphate groups are major structural components of nucleotides, which are the building blocks for nucleic acids like DNA and RNA. Phospholipids — which contain a hydrophobic fatty acid “tail” and a hydrophilic phosphate “head” — form lipid bilayers that constitute cellular membranes.

Most cellular metabolic reactions are driven by chemical energy harnessed from the cleavage of adenosine triphosphate, a molecule that contains a sugar, a nitrogenous base and three phosphate groups. The addition of phosphoryl groups to proteins during phosphorylation changes protein activity and/or cellular localization, regulating a plethora of cell-signaling events.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Quira Zeidan

Quira Zeidan is the ASBMB’s education and public outreach coordinator.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.